Feed / ALHC

Alignment Healthcare, Inc.

ALHC

Healthcare · 12.60 -1.1% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:55 GMT-4

Market read

Alignment Healthcare, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Company-1.1% todayVolume comparison unavailable
Market group0 of 1 activeMedicare Advantage · unavailable
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • Membership increased 31.5% between June 30, 2025 and June 30, 2026.

Invalidation: The isolated read changes if ALHC's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Healthcare Plans

No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • Membership increased 31.5% between June 30, 2025 and June 30, 2026.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods7
Price observations328
Usable filing statements91
Verified relationships4
Evidence supporting the case
  • Latest annual revenue changed +46.1% year over year.
  • Operating margin changed +4.1 percentage points in the latest annual period.
  • Net margin changed +4.7 percentage points in the latest annual period.
Evidence challenging the case
  • Diluted shares increased 3.8% in the latest annual period.
  • Credit and interest rates has repeated adverse evidence across 4 filings.
Questions before a position
  • EV/sales is 38% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 11, 2026

12.60
6m-26.4%12m-23.4%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$1.2B+22.2%$-1.14+19.0%
2022-12-31$1.4B+22.9%$-0.83-0.4%
2023-12-31$1.8B+27.2%$-0.79+2.8%
2024-12-31$2.7B+48.3%$-0.67+2.5%
2025-12-31$3.9B+46.1%$0.00+3.8%

What management says matters

Persistent and emerging business drivers

Capital investment and capacitymixed · 4 filings
The increase was primarily due to the amount and timing of our capital expenditures and the 33 associated depreciation relative to 2025.
10-Q · Jul 30, 2026
Credit and interest ratesnegative · 4 filings
The increase in interest expense was mainly attributable to an increase in debt issuance cost amortization related to the Revolving Credit Facility that was entered into in February 2026.
10-Q · Jul 30, 2026
Macroeconomic conditionsmixed · 3 filings
During periods of economic downturn or high unemployment, governmental entities often experience budget deficits as a result of increased costs and lower than expected tax collections.
10-K · Feb 27, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 0.6× · EV/sales 0.6×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

12.60-1.1% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for ALHC. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for ALHC. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind ALHC

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

CIThe Cigna GroupcompetitorFeb 27, 2026

Many of the other companies currently providing health insurance coverage and healthcare services, particularly national insurers such as United Health, Aetna, Humana and Cigna, have been in business longer and/or have substantially more resources than we do.

HUMHumana Inc.competitorFeb 27, 2026

Many of the other companies currently providing health insurance coverage and healthcare services, particularly national insurers such as United Health, Aetna, Humana and Cigna, have been in business longer and/or have substantially more resources than we do.

STHOFiling-linked namecompetitorFeb 27, 2026

While health plans compete on the basis of many factors, including service and the quality and depth of provider networks, we expect that price and Star ratings will continue to be significant bases of competition.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ALHC is currently a Leader in the organic co-movement group Medicare Advantage. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ALHC; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.